Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-2pzkn Total loading time: 0 Render date: 2024-06-06T10:50:08.085Z Has data issue: false hasContentIssue false

Appendix I

Published online by Cambridge University Press:  03 March 2010

Shaili Jain
Affiliation:
Aurora Medical Group, Milwaukee, Wisconsin
Get access

Summary

Over time, many gifts to physicians from pharmaceutical, device and medical equipment industry sales representatives have served an important and beneficial function. For example, industry has provided funds for educational seminars and conferences for many years.

During the late 1980's, however, some of these gifts were becoming lavish, ranging from frequent flier miles to cash and trips to luxury resorts, and their appropriateness was increasingly being called into question. The AMA studied the issue, and in December of 1990, the AMA's House of Delegates adopted CEJA's ethical guidelines to prevent inappropriate gift-giving practices. The AMA's “Guidelines on Gifts to Physicians from Industry” later appeared in its Code of Medical Ethics (CEJA Ethical Opinion 8.061).

The Pharmaceutical Manufacturer's Association (PMA), which later became PhRMA (Pharmaceutical Research and Manufacturers of America), also adopted the guidelines.

Opinion 8.061, “Gifts to Physicians from Industry”

Many gifts given to physicians by companies in the pharmaceutical, device, and medical equipment industries serve an important and socially beneficial function. For example, companies have long provided funds for educational seminars and conferences. However, there has been growing concern about certain gifts from industry to physicians. Some gifts that reflect customary practices of industry may not be consistent with the Principles of Medical Ethics.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

The Pharmaceutical Research and Manufacturers of America (PhRMA). New medicines new hope (annual report). 2001–2002. Available from URL: www.phrma/org.publications/publications/annual2001. Accessed 10/18/01.
Wazana, A. Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA 2000 Jan 19; 283(3):373–80.CrossRefGoogle Scholar
Hammond C. In the business. Endeavors. University of North Carolina at Chapel Hill: 1999. Available from URL: http://research.unc.edu/endeavors/fall99/business.htm. Accessed 01/03/02.
Ross J, Lurie P, Wolfe S. Medical education service suppliers: a threat to physician education. Public Citizen's Health Research Group 2000 July 19. Available from URL: http://www.citizen.org/publications/release.cfm?ID=7142. Accessed 01/14/02.
Rennie, D. Thyroid storm. JAMA 1997 April 16; 277(15):1238–43.CrossRefGoogle Scholar
Relman, A. Separating continuing medical education from pharmaceutical marketing. JAMA 2001 Apr 18; 285(15):2009–12.CrossRefGoogle Scholar
Chren, M, Landefeld, C. Physicians' behavior and their interactions with drug companies. JAMA 1994 Mar 2; 271(9):684–89.CrossRefGoogle Scholar
Orlowski, J, Wateska, L. The effects of pharmaceutical firm enticements on physician prescribing patterns. there's no such thing as a free lunch. Chest 1992; 102:270–73.CrossRefGoogle ScholarPubMed
Hafferty, F. Beyond curriculum reform: confronting medicine's hidden curriculum. Acad Med 1998 April 73(4):403–7.
Stern, D. In search of the informal curriculum: when and where professional values are taught. Acad Med 1998 Oct 73(10 Suppl 1):S-28–30.CrossRefGoogle Scholar
Rothman, D. Medical professionalism—focusing on the real issues. N Engl J Med 2000 342(17):1284–6.CrossRefGoogle ScholarPubMed
Kassirer, J. Financial indigestion. JAMA 2000 Nov 1; 284(17):2156–57.Google Scholar
Eichenwald, K, Kolata, G. Drug trials hide conflicts for doctors. NY Times 1999 May 16;Sect.1 (national).Google Scholar
Council on Ethical and Judicial Affairs. Gifts to physicians from industry. (E-8.061) American Medical Association (AMA). 2001. Available from URL: www.ama-assn.org/ama/pub/article/4001-4236.html. Accessed 10/30/01.
Coyle, S L for the Ethics and Human Rights Committee, American College of Physicians—American Society of Internal Medicine. Physician–industry relations. Part 1: Individual physicians. Ann Intern Med 2002 March 5; 136(5):396–402.CrossRefGoogle Scholar
Coyle, S L for the Ethics and Human Rights Committee, American College of Physicians—American Society of Internal Medicine. Physician–industry relations. Part 2: Organizational issues. Ann Intern Med 2002 March 5; 136(5):403–6.CrossRefGoogle Scholar
Canadian Medical Association (CMA). Physicians and the pharmaceutical industry. 2001. Available from URL: http://www.cma.ca/staticContent/HTML/N0/12/ where we stand/physicians and the pharmaceutical industry.pdf. Accessed 01/03/02.
Accreditation Council for Continuing Medical Education (ACCME). Standards for Commercial Support of Continuing Medical Education. 2001 Available from URL: www.accme.org/pdfs/disclosure pol.pdf. Accessed 10/30/01.
Task Force on Financial Conflicts of Interest in Research. Protecting subjects, preserving trust, promoting progress: Policy and guidelines for the oversight of individual financial interests in human subjects research. Association of American Medical Colleges. 2002. Available from URL: http://www.aamc.org/members/coitf/firstreport.pdf. Accessed 3/11/02.
Accreditation Council for Graduate Medical Education (ACGME). General competencies. 2001. Available from URL: http://www.acgme.org/outcome/comp/compFull.asp. Accessed 10/16/01.
Kuczewski M. Developing competency in professionalism: the potential and the pitfalls. ACGME Bulletin 2001 October;3–6.
Arnold L. Assessing professionalism: from concept to construct. Acad Med. In press, 2001.
Ginsburg, S, Regehr, G, Hatala, R, McNaughton, N, Frohna, A, Hodges, B. Context, conflict, and resolution: a new conceptual framework for evaluating professionalism. Acad Med 2000;75 Suppl: S6-11.CrossRefGoogle ScholarPubMed
McCormick, B, Tomlinson, G, Brill-Edwards, P, Detsky, A. Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behaviors. JAMA 2001 Oct 24/31; 286(16):1994–99.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Appendix I
  • Shaili Jain
  • Book: Understanding Physician-Pharmaceutical Industry Interactions
  • Online publication: 03 March 2010
  • Chapter DOI: https://doi.org/10.1017/CBO9780511665677.016
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Appendix I
  • Shaili Jain
  • Book: Understanding Physician-Pharmaceutical Industry Interactions
  • Online publication: 03 March 2010
  • Chapter DOI: https://doi.org/10.1017/CBO9780511665677.016
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Appendix I
  • Shaili Jain
  • Book: Understanding Physician-Pharmaceutical Industry Interactions
  • Online publication: 03 March 2010
  • Chapter DOI: https://doi.org/10.1017/CBO9780511665677.016
Available formats
×